SCHEMBL4027301

SCHEMBL4027301

COCCC#Cc1cc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)cc(OC(C)C)c23)c2c1OCO2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 20/20 0.66
KDR P35968 16/20 0.66
EGFR P00533 2/20 0.52
LCK P06239 2/20 0.52
YES1 P07947 2/20 0.52
CSK P41240 2/20 0.52
FGFR1 P11362 1/20 0.52
AURKB Q96GD4 1/20 0.52
BMPR1B O00238 1/20 0.48
GAK O14976 1/20 0.48
EPHB6 O15197 1/20 0.48
RIPK2 O43353 1/20 0.48
STK10 O94804 1/20 0.48
MAP4K4 O95819 1/20 0.48
ABL1 P00519 1/20 0.48
FYN P06241 1/20 0.48
LYN P07948 1/20 0.48
RET P07949 1/20 0.48
HCK P08631 1/20 0.48
PDGFRB P09619 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4021115 0.90 SRC (0.66) SRCKDREGFRLCKYES1
SCHEMBL4026632 0.87 SRC (0.65) SRCKDREGFRLCKYES1
SCHEMBL4028427 0.86 SRC (0.61) SRCKDREGFRLCKYES1
SCHEMBL4024957 0.86 SRC (0.73) SRCKDREGFRLCKYES1
SCHEMBL4021818 0.85 SRC (0.62) SRCKDREGFRLCKYES1
SCHEMBL4027114 0.84 SRC (0.67) SRCKDREGFRLCKYES1
SCHEMBL4025884 0.84 SRC (0.57) SRCKDREGFR
SCHEMBL3672594 0.84 SRC (0.75) SRCKDREGFRLCKYES1
SCHEMBL4023023 0.84 SRC (0.59) SRCKDREGFRLCKYES1
SCHEMBL4024497 0.82 SRC (0.70) SRCKDREGFRLCKCSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528925-B1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2009-04-22 EP disclosed
EP-1528925-A1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER Astrazeneca AB (SE) 2005-05-11 EP disclosed
WO-2004004732-A1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2004-01-15 WO disclosed